182 related articles for article (PubMed ID: 31935064)
1. Combined Magnetic Hyperthermia and Immune Therapy for Primary and Metastatic Tumor Treatments.
Pan J; Hu P; Guo Y; Hao J; Ni D; Xu Y; Bao Q; Yao H; Wei C; Wu Q; Shi J
ACS Nano; 2020 Jan; 14(1):1033-1044. PubMed ID: 31935064
[TBL] [Abstract][Full Text] [Related]
2. Temperature-controlled magnetic nanoparticles hyperthermia inhibits primary tumor growth and metastases dissemination.
Garanina AS; Naumenko VA; Nikitin AA; Myrovali E; Petukhova AY; Klimyuk SV; Nalench YA; Ilyasov AR; Vodopyanov SS; Erofeev AS; Gorelkin PV; Angelakeris M; Savchenko AG; Wiedwald U; Majouga Dr AG; Abakumov MA
Nanomedicine; 2020 Apr; 25():102171. PubMed ID: 32084594
[TBL] [Abstract][Full Text] [Related]
3. Iron Nanoparticles for Low-Power Local Magnetic Hyperthermia in Combination with Immune Checkpoint Blockade for Systemic Antitumor Therapy.
Chao Y; Chen G; Liang C; Xu J; Dong Z; Han X; Wang C; Liu Z
Nano Lett; 2019 Jul; 19(7):4287-4296. PubMed ID: 31132270
[TBL] [Abstract][Full Text] [Related]
4. Mild Magnetic Hyperthermia-Activated Innate Immunity for Liver Cancer Therapy.
Pan J; Xu Y; Wu Q; Hu P; Shi J
J Am Chem Soc; 2021 Jun; 143(21):8116-8128. PubMed ID: 33928777
[TBL] [Abstract][Full Text] [Related]
5. In vitro study on apoptotic cell death by effective magnetic hyperthermia with chitosan-coated MnFe₂O₄.
Oh Y; Lee N; Kang HW; Oh J
Nanotechnology; 2016 Mar; 27(11):115101. PubMed ID: 26871973
[TBL] [Abstract][Full Text] [Related]
6. Surface-Functionalized Modified Copper Sulfide Nanoparticles Enhance Checkpoint Blockade Tumor Immunotherapy by Photothermal Therapy and Antigen Capturing.
Wang R; He Z; Cai P; Zhao Y; Gao L; Yang W; Zhao Y; Gao X; Gao F
ACS Appl Mater Interfaces; 2019 Apr; 11(15):13964-13972. PubMed ID: 30912920
[TBL] [Abstract][Full Text] [Related]
7. Enhanced magnetic fluid hyperthermia by micellar magnetic nanoclusters composed of Mn(x)Zn(1-x)Fe(2)O(4) nanoparticles for induced tumor cell apoptosis.
Qu Y; Li J; Ren J; Leng J; Lin C; Shi D
ACS Appl Mater Interfaces; 2014 Oct; 6(19):16867-79. PubMed ID: 25204363
[TBL] [Abstract][Full Text] [Related]
8. Spatial, Temporal, and Dose Control of Drug Delivery using Noninvasive Magnetic Stimulation.
Chen W; Cheng CA; Zink JI
ACS Nano; 2019 Feb; 13(2):1292-1308. PubMed ID: 30633500
[TBL] [Abstract][Full Text] [Related]
9. Depleting tumor-associated Tregs via nanoparticle-mediated hyperthermia to enhance anti-CTLA-4 immunotherapy.
Chen H; Luan X; Paholak HJ; Burnett JP; Stevers NO; Sansanaphongpricha K; He M; Chang AE; Li Q; Sun D
Nanomedicine (Lond); 2020 Jan; 15(1):77-92. PubMed ID: 31868112
[No Abstract] [Full Text] [Related]
10. Tailoring Mg(x)Mn(1-x)Fe(2)O(4) superparamagnetic nanoferrites for magnetic fluid hyperthermia applications.
Jeun M; Park S; Jang GH; Lee KH
ACS Appl Mater Interfaces; 2014 Oct; 6(19):16487-92. PubMed ID: 25238143
[TBL] [Abstract][Full Text] [Related]
11. Tumor microenvironment-responsive multifunctional nanoplatform based on MnFe
He Z; Yan H; Zeng W; Yang K; Rong P
J Mater Chem B; 2021 Feb; 9(6):1625-1637. PubMed ID: 33475658
[TBL] [Abstract][Full Text] [Related]
12. Using thermal energy produced by irradiation of Mn-Zn ferrite magnetic nanoparticles (MZF-NPs) for heat-inducible gene expression.
Tang QS; Zhang DS; Cong XM; Wan ML; Jin LQ
Biomaterials; 2008 Jun; 29(17):2673-9. PubMed ID: 18396332
[TBL] [Abstract][Full Text] [Related]
13. Comparative Heating Efficiency of Cobalt-, Manganese-, and Nickel-Ferrite Nanoparticles for a Hyperthermia Agent in Biomedicines.
Demirci Dönmez ÇE; Manna PK; Nickel R; Aktürk S; van Lierop J
ACS Appl Mater Interfaces; 2019 Feb; 11(7):6858-6866. PubMed ID: 30676734
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of CD8
Zhang Y; Gao X; Yan B; Wen N; Lee WSV; Liang XJ; Liu X
ChemMedChem; 2022 Jan; 17(2):e202100656. PubMed ID: 34806311
[TBL] [Abstract][Full Text] [Related]
15. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.
Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I
Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050
[TBL] [Abstract][Full Text] [Related]
16. In situ thermal ablation of tumors in combination with nano-adjuvant and immune checkpoint blockade to inhibit cancer metastasis and recurrence.
Han X; Wang R; Xu J; Chen Q; Liang C; Chen J; Zhao J; Chu J; Fan Q; Archibong E; Jiang L; Wang C; Liu Z
Biomaterials; 2019 Dec; 224():119490. PubMed ID: 31542515
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Characterization and Magnetic Hyperthermia of Monodispersed Cobalt Ferrite Nanoparticles for Cancer Therapeutics.
Medina MA; Oza G; Ángeles-Pascual A; González M M; Antaño-López R; Vera A; Leija L; Reguera E; Arriaga LG; Hernández Hernández JM; Ramírez JT
Molecules; 2020 Sep; 25(19):. PubMed ID: 32992439
[TBL] [Abstract][Full Text] [Related]
18. Magnetic-responsive and targeted cancer nanotheranostics by PA/MR bimodal imaging-guided photothermally triggered immunotherapy.
Guo Y; Ran Y; Wang Z; Cheng J; Cao Y; Yang C; Liu F; Ran H
Biomaterials; 2019 Oct; 219():119370. PubMed ID: 31357006
[TBL] [Abstract][Full Text] [Related]
19. Exploiting Unique Alignment of Cobalt Ferrite Nanoparticles, Mild Hyperthermia, and Controlled Intrinsic Cobalt Toxicity for Cancer Therapy.
Balakrishnan PB; Silvestri N; Fernandez-Cabada T; Marinaro F; Fernandes S; Fiorito S; Miscuglio M; Serantes D; Ruta S; Livesey K; Hovorka O; Chantrell R; Pellegrino T
Adv Mater; 2020 Nov; 32(45):e2003712. PubMed ID: 33002227
[TBL] [Abstract][Full Text] [Related]
20. Laser Immunotherapy in Combination with Perdurable PD-1 Blocking for the Treatment of Metastatic Tumors.
Luo L; Zhu C; Yin H; Jiang M; Zhang J; Qin B; Luo Z; Yuan X; Yang J; Li W; Du Y; You J
ACS Nano; 2018 Aug; 12(8):7647-7662. PubMed ID: 30020768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
